What is the address of Dr. David Perquy, Heelkunde?

The registered office of Dr. David Perquy, Heelkunde is located at Moorselstraat 360, 3080 Tervuren.

Is Dr. David Perquy, Heelkunde still active?

Yes. According to the CBE (18 September 2026) Dr. David Perquy, Heelkunde is active, legal situation “Normale toestand”, started on 1 August 2022.

Is Dr. David Perquy, Heelkunde registered on Peppol?

Yes, Dr. David Perquy, Heelkunde is registered on the Peppol network with ID 0208:0789261878.

What is the enterprise number of Dr. David Perquy, Heelkunde?

The enterprise number of Dr. David Perquy, Heelkunde is BE0789261878.

When was Dr. David Perquy, Heelkunde founded?

Dr. David Perquy, Heelkunde was founded on 1 August 2022.

Who are the directors of Dr. David Perquy, Heelkunde?

According to the 2025 annual accounts, the directors of Dr. David Perquy, Heelkunde are: David PERQUY.

Is Dr. David Perquy, Heelkunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 August 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. David Perquy, Heelkunde make in 2025?

Dr. David Perquy, Heelkunde posted a profit after taxes of € 170,134 in financial year 2025.

What is the revenue of Dr. David Perquy, Heelkunde?

As a small company, Dr. David Perquy, Heelkunde is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 222,420.

Dr. David Perquy, Heelkunde (Private Limited) - Tervuren

Dossier Dr. David Perquy, Heelkunde, printed on 18 September 2026 from databakkes.be/en/0789261878/dr-david-perquy-heelkunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. David Perquy, Heelkunde from Tervuren, company number BE0789261878, closed financial year 2025 with a result of € 170,134 after tax. For that financial year Dr. David Perquy, Heelkunde recorded a gross margin of € 222,420 and equity of € 39,292. Compared with financial year 2024, the result moved from € 184,157 to € 170,134. The company is profitable. The buffer shrank hard: equity is 90 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Shrank hard

€ 39,292

▼ 90% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 170,134

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 100,961

▼ 62% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 540,529 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,807

▼ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,250

▼ 95% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 79,719 Gross margin 2022: € 79,719 First fiscal year in the series	€ 194,660 Gross margin 2023: € 194,660 ▲ 144% vs 2022 (€ 79,719) Favourable step	€ 243,633 Gross margin 2024: € 243,633 ▲ 25% vs 2023 (€ 194,660) Favourable step	€ 222,420 Gross margin 2025: € 222,420 ▼ 9% vs 2024 (€ 243,633) Unfavourable step	▼ 9%
Profit after taxes	€ 62,596 Profit after taxes 2022: € 62,596 First fiscal year in the series	€ 147,932 Profit after taxes 2023: € 147,932 ▲ 136% vs 2022 (€ 62,596) Favourable step	€ 184,157 Profit after taxes 2024: € 184,157 ▲ 24% vs 2023 (€ 147,932) Favourable step	€ 170,134 Profit after taxes 2025: € 170,134 ▼ 8% vs 2024 (€ 184,157) Unfavourable step	▼ 8%
Equity	€ 77,596 Equity 2022: € 77,596 First fiscal year in the series	€ 225,529 Equity 2023: € 225,529 ▲ 191% vs 2022 (€ 77,596) Favourable step	€ 409,686 Equity 2024: € 409,686 ▲ 82% vs 2023 (€ 225,529) Favourable step	€ 39,292 Equity 2025: € 39,292 ▼ 90% vs 2024 (€ 409,686) Unfavourable step	▼ 90%
Total debts	€ 23,106 Total debts 2022: € 23,106 First fiscal year in the series	€ 50,654 Total debts 2023: € 50,654 ▲ 119% vs 2022 (€ 23,106) Unfavourable step	€ 67,552 Total debts 2024: € 67,552 ▲ 33% vs 2023 (€ 50,654) Unfavourable step	€ 291,988 Total debts 2025: € 291,988 ▲ € 224,436 vs 2024 (€ 67,552) Unfavourable step	▲ € 224,436
Cash	€ 572 Cash 2022: € 572 First fiscal year in the series	€ 113,645 Cash 2023: € 113,645 ▲ € 113,072 vs 2022 (€ 572) Favourable step	€ 267,454 Cash 2024: € 267,454 ▲ 135% vs 2023 (€ 113,645) Favourable step	€ 100,961 Cash 2025: € 100,961 ▼ 62% vs 2024 (€ 267,454) Unfavourable step	▼ 62%
Retained profit	€ 62,596 Retained profit 2022: € 62,596 First fiscal year in the series	€ 210,529 Retained profit 2023: € 210,529 ▲ 236% vs 2022 (€ 62,596) Favourable step	€ 394,686 Retained profit 2024: € 394,686 ▲ 87% vs 2023 (€ 210,529) Favourable step	€ 24,292 Retained profit 2025: € 24,292 ▼ 94% vs 2024 (€ 394,686) Unfavourable step	▼ 94%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 540,529 Dividend 2025: € 540,529 Unchanged (€ 0) Unchanged
Balance sheet total	€ 100,703 Balance sheet total 2022: € 100,703 First fiscal year in the series	€ 276,183 Balance sheet total 2023: € 276,183 ▲ 174% vs 2022 (€ 100,703) Unchanged	€ 477,238 Balance sheet total 2024: € 477,238 ▲ 73% vs 2023 (€ 276,183) Unchanged	€ 331,280 Balance sheet total 2025: € 331,280 ▼ 31% vs 2024 (€ 477,238) Unchanged	▼ 31%

Key figures of Dr. David Perquy, Heelkunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. David Perquy, Heelkunde?

What happened at Dr. David Perquy, Heelkunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 170,134 (▼ 8% vs 2024). Source: NBB ↗
Aug 1, 2022 New establishment in Tervuren. KBO
2022 David PERQUY became a director. NBB
Aug 1, 2022 Start of the company according to the CBE. KBO

In short

From € 62,596 profit in 2022 to € 170,134 profit in 2025.

Paid € 171,127 in corporate taxes since 2022.

Best year ever: 2024, with € 184,157 profit.

Paid out € 540,529 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. David Perquy, Heelkunde? We notify you, reason included.

Follow Dr. David Perquy, Heelkunde

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

David PERQUY

Dr. David Perquy, Heelkunde

Behind Dr. David Perquy, Heelkunde is David PERQUY.

See the full network in the app

Directors

According to the 2025 annual accounts

David PERQUY

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Moorselstraat 360

3080 Tervuren

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. René Scheer, Heelkunde

€ 277,018 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0789.261.878
VAT number: BE 0789.261.878
Registered office: Moorselstraat 360, 3080 Tervuren
Names & denominations: Dr. David Perquy, Heelkunde
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 August 2022
Peppol: Active · Active since 17 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗